转录组
癌症研究
甲状腺癌
生物
表型
人口
免疫疗法
癌
甲状腺癌
甲状腺乳突癌
甲状腺
癌症
医学
基因表达
病理
基因
内分泌学
遗传学
环境卫生
作者
Weilin Pu,Xiao Shi,Pengcheng Yu,Meiying Zhang,Zhiyan Liu,Licheng Tan,Peizhen Han,Yu Wang,Dongmei Ji,Hualei Gan,Wenjun Wei,Zhong‐Wu Lu,Ning Qu,Jia‐Qian Hu,Xiaohua Hu,Zaili Luo,Huajun Li,Qinghai Ji,Jiucun Wang,Xiaoming Zhang,Yulong Wang
标识
DOI:10.1038/s41467-021-26343-3
摘要
Abstract The tumor ecosystem of papillary thyroid carcinoma (PTC) is poorly characterized. Using single-cell RNA sequencing, we profile transcriptomes of 158,577 cells from 11 patients’ paratumors, localized/advanced tumors, initially-treated/recurrent lymph nodes and radioactive iodine (RAI)-refractory distant metastases, covering comprehensive clinical courses of PTC. Our data identifies a “cancer-primed” premalignant thyrocyte population with normal morphology but altered transcriptomes. Along the developmental trajectory, we also discover three phenotypes of malignant thyrocytes (follicular-like, partial-epithelial-mesenchymal-transition-like, dedifferentiation-like), whose composition shapes bulk molecular subtypes, tumor characteristics and RAI responses. Furthermore, we uncover a distinct BRAF -like-B subtype with predominant dedifferentiation-like thyrocytes, enriched cancer-associated fibroblasts, worse prognosis and promising prospect of immunotherapy. Moreover, potential vascular-immune crosstalk in PTC provides theoretical basis for combined anti-angiogenic and immunotherapy. Together, our findings provide insight into the PTC ecosystem that suggests potential prognostic and therapeutic implications.
科研通智能强力驱动
Strongly Powered by AbleSci AI